2-(1H-tetrazol-5-yl)aniline hydrate, 95.0%, 10g

5-(4-piperidinyl)-4H-1,2,4-triazol-3-amine dihydrochloride, 95.0%, 250mg

Vinyltoluene Monomer (m- and p- mixture) (stabilized with TBC)>98.0%(GC)500mL

(S)-2-Amino-3-(3,5-dichlorophenyl)propanoic acid, 95.0%, 1g

4-Pyridylacetic acid hydrochloride, 95.0%, 1g

3-Amino-5-methyl-4H-1,2,4-triazole, 97.0%, 25g

4-(2-Hydroxyethyl)morpholine>99.0%(GC)25mL

5,8-Dichloro-1,7-naphthyridine, 98%, 10g

4-Methylisoquinoline-5-sulfonyl chloride, 95.0%, 250mg

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 5g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 10mg

2-{[5-(trifluoromethyl)pyridin-2-yl]sulfanyl}acetic acid, 97%, 5g

(5-Chloro-2-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 1g